Life Sciences Ireland Series - IP Strategies for Success

Our next event in our Life Sciences Ireland series will focus on IP strategies for success. We will discuss key insights on how to formulate a successful IP strategy for corporates in the life sciences sector.

Chaired by Ann Henry, Intellectual Property and Data Protection Partner at Pinsent Masons (Ireland) we will be joined by keynote speaker Gerard Barrett, Controller, Intellectual Property Office of Ireland, Corey Salsberg, Vice President, Global Head IP Affairs at Novartis, Washington D.C., and Liam Diamond, Lead for the FDI Tax Group at PwC Ireland.

Each of our esteemed speakers will share hints and tips on how to formulate a successful IP strategy in the life sciences sector. Topics will include: 

• Gerard Barrett, Controller, Intellectual Property Office of Ireland is our keynote speaker. He will discuss trends evident in IP registrations in the Life Sciences sector in addition to the regulatory issues and challenges which he believes will impact IP strategies in Ireland and the EU going forward including Brexit and the UPC.

• Corey Salsberg is Vice President, Global Head IP Affairs at Novartis, Washington D.C. and a well-known international thought leader in this area. He will discuss how success for Novartis is defined by practical IP strategies that enable and follow the science and which take account of the realities of biopharma R&D – long development timelines and big scientific bets.

• Liam Diamond, Lead for the FDI Tax Group at PwC Ireland will focus on IP tax planning and optimisation. He will discuss how a smart IP tax strategy will focus on factoring in the lifecycle of R&D development, how Ireland will remain attractive to international life science companies looking to expand across Europe and key issues to watch for in 2021.

Who should attend?

IP leads, Senior Executives and GCs operating in the pharma, tech and healthcare industries.